The global etoricoxib intermediate market is projected to grow at a CAGR of 5.5% from 2022 to 2028. Etoricoxib is a moderate analgesic with short and long term benefits. Its benefits include its ability to reduce inflammation, pain, and swelling. It can improve the function of people with arthritis. Also, because etoricoxib is a non-steroidal […]
